Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R.

PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.

2.

Validation of the Quantitative Checklist for Autism in Toddlers in an Italian Clinical Sample of Young Children With Autism and Other Developmental Disorders.

Ruta L, Chiarotti F, Arduino GM, Apicella F, Leonardi E, Maggio R, Carrozza C, Chericoni N, Costanzo V, Turco N, Tartarisco G, Gagliano A, Allison C, Baron Cohen S, Pioggia G, Muratori F.

Front Psychiatry. 2019 Jul 17;10:488. doi: 10.3389/fpsyt.2019.00488. eCollection 2019.

3.

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.

Marampon F, Leoni F, Mancini A, Pietrantoni I, Codenotti S, Ferella L, Megiorni F, Porro G, Galbiati E, Pozzi P, Mascagni P, Budillon A, Maggio R, Tombolini V, Fanzani A, Gravina GL, Festuccia C.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2411. doi: 10.1007/s00432-019-02980-6.

PMID:
31346710
4.

Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.

Vitrano A, Ruffo GB, Pepe A, D'Ascola DG, Caruso V, Filosa A, Masera N, Pitrolo L, Rigano P, Cuccia L, Giangreco A, Di Maggio R, Maggio A.

Br J Haematol. 2019 Sep;186(6):e209-e211. doi: 10.1111/bjh.16101. Epub 2019 Jul 25. No abstract available.

PMID:
31344255
5.

Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines.

Marampon F, Di Nisio V, Pietrantoni I, Petragnano F, Fasciani I, Scicchitano BM, Ciccarelli C, Gravina GL, Festuccia C, Del Fattore A, Tombolini M, De Felice F, Musio D, Cecconi S, Tini P, Maddalo M, Codenotti S, Fanzani A, Polimeni A, Maggio R, Tombolini V.

Cancer Lett. 2019 Oct 1;461:90-101. doi: 10.1016/j.canlet.2019.07.009. Epub 2019 Jul 17.

PMID:
31325529
6.

Parkinson's disease and light: The bright and the Dark sides.

Maggio R, Vaglini F, Rossi M, Fasciani I, Pietrantoni I, Marampon F, Corsini GU, Scarselli M, Millan MJ.

Brain Res Bull. 2019 Aug;150:290-296. doi: 10.1016/j.brainresbull.2019.06.013. Epub 2019 Jun 19. Review.

PMID:
31226407
7.

Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program.

De Felice F, Megiorni F, Pietrantoni I, Tini P, Lessiani G, Mastroiacovo D, Mattana P, Antinozzi C, Di Luigi L, Delle Monache S, Angelucci A, Festuccia C, Fanzani A, Maggio R, Tombolini V, Gravina GL, Marampon F.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2669-2680. doi: 10.26355/eurrev_201903_17415.

8.

Development and validation of a green method for dissolution monitoring of pharmaceutical combinations. Meloxican and pridinol.

Salazar-Rojas D, Intilangelo A, Vignaduzzo SE, Maggio RM.

J Pharm Biomed Anal. 2019 Jun 5;170:228-233. doi: 10.1016/j.jpba.2019.03.038. Epub 2019 Mar 18.

PMID:
30933898
9.

Chemometric study of the excipients' influence on polymorphic-behavior. Mefenamic acid as case of study.

Antonio M, Calvo NL, Maggio RM.

J Pharm Biomed Anal. 2019 Jun 5;170:8-15. doi: 10.1016/j.jpba.2019.03.021. Epub 2019 Mar 14.

PMID:
30901720
10.

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.

Aurisicchio L, Salvatori E, Lione L, Bandini S, Pallocca M, Maggio R, Fanciulli M, De Nicola F, Goeman F, Ciliberto G, Conforti A, Luberto L, Palombo F.

J Exp Clin Cancer Res. 2019 Feb 14;38(1):78. doi: 10.1186/s13046-019-1084-4.

11.

Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.

Vomero M, Manganelli V, Barbati C, Colasanti T, Capozzi A, Finucci A, Spinelli FR, Ceccarelli F, Perricone C, Truglia S, Morrone S, Maggio R, Misasi R, Bombardieri M, Di Franco M, Conti F, Sorice M, Valesini G, Alessandri C.

Arthritis Res Ther. 2019 Jan 29;21(1):39. doi: 10.1186/s13075-019-1818-x.

12.

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.

Marampon F, Leoni F, Mancini A, Pietrantoni I, Codenotti S, Letizia F, Megiorni F, Porro G, Galbiati E, Pozzi P, Mascagni P, Budillon A, Maggio R, Tombolini V, Fanzani A, Gravina GL, Festuccia C.

J Cancer Res Clin Oncol. 2019 Feb;145(2):393-409. doi: 10.1007/s00432-018-2800-8. Epub 2018 Nov 24. Erratum in: J Cancer Res Clin Oncol. 2019 Sep;145(9):2411.

PMID:
30474756
13.

Spatial Integration of Somatosensory Inputs during Sensory-Motor Plasticity Phenomena Is Normal in Focal Hand Dystonia.

Terranova C, Rizzo V, Morgante F, Maggio R, Calamuneri A, Chillemi G, Girlanda P, Quartarone A.

Neural Plast. 2018 Oct 10;2018:4135708. doi: 10.1155/2018/4135708. eCollection 2018.

14.

Sickle related events following cardiac catheterisation: risk implication for other invasive procedures.

Di Maggio R, Conrey A, Taylor TN, Lederman RJ, Rogers T, Nichols J, Bouges S, Minniti CP, Kato GJ, Shet AS, Hsieh MM.

Br J Haematol. 2019 May;185(4):778-780. doi: 10.1111/bjh.15618. Epub 2018 Oct 23. No abstract available.

15.

8q22.1 Microduplication Syndrome: Why the Brain Should Be Spared? A Literature Review and a Case Report.

Gagliano A, Pironti E, Cucinotta F, Galati C, Maggio R, Alquino MA, Di Rosa G.

Case Rep Med. 2018 Jul 12;2018:3871425. doi: 10.1155/2018/3871425. eCollection 2018.

16.

Chemometrics-assisted study of the interconversion between the crystalline forms of nimodipine.

Calvo NL, Balzaretti NM, Antonio M, Kaufman TS, Maggio RM.

J Pharm Biomed Anal. 2018 Sep 5;158:461-470. doi: 10.1016/j.jpba.2018.06.019. Epub 2018 Jun 18.

PMID:
29960237
17.

Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.

Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M.

Pharmacol Ther. 2018 Dec;192:20-41. doi: 10.1016/j.pharmthera.2018.06.012. Epub 2018 Jun 25. Review.

PMID:
29953902
18.

β-Thalassemia heterozygote state detrimentally affects health expectation.

Graffeo L, Vitrano A, Scondotto S, Dardanoni G, Pollina Addario WS, Giambona A, Sacco M, Di Maggio R, Renda D, Taormina F, Triveri A, Attanasio M, Gluud C, Maggio A.

Eur J Intern Med. 2018 Aug;54:76-80. doi: 10.1016/j.ejim.2018.06.009. Epub 2018 Jun 19. Review.

PMID:
29934240
19.

Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.

Di Maggio R, Hsieh MM, Zhao X, Calvaruso G, Rigano P, Renda D, Tisdale JF, Maggio A.

Int J Mol Sci. 2018 Feb 28;19(3). pii: E681. doi: 10.3390/ijms19030681.

20.

HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes.

Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M.

Mediators Inflamm. 2017;2017:7435621. doi: 10.1155/2017/7435621. Epub 2017 Dec 17.

21.

Environmental stimuli shape microglial plasticity in glioma.

Garofalo S, Porzia A, Mainiero F, Di Angelantonio S, Cortese B, Basilico B, Pagani F, Cignitti G, Chece G, Maggio R, Tremblay ME, Savage J, Bisht K, Esposito V, Bernardini G, Seyfried T, Mieczkowski J, Stepniak K, Kaminska B, Santoni A, Limatola C.

Elife. 2017 Dec 29;6. pii: e33415. doi: 10.7554/eLife.33415.

22.

Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors.

Fasciani I, Pietrantoni I, Rossi M, Mannoury la Cour C, Aloisi G, Marampon F, Scarselli M, Millan MJ, Maggio R.

Eur J Pharmacol. 2018 Jan 15;819:181-189. doi: 10.1016/j.ejphar.2017.12.002. Epub 2017 Dec 6.

PMID:
29223348
23.

Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy.

Lozanoska-Ochser B, Benedetti A, Rizzo G, Marrocco V, Di Maggio R, Fiore P, Bouche M.

J Pathol. 2018 Mar;244(3):323-333. doi: 10.1002/path.5016. Epub 2018 Jan 9.

PMID:
29214629
24.

Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.

Antonio M, Maggio RM.

J Pharm Biomed Anal. 2018 Feb 5;149:603-611. doi: 10.1016/j.jpba.2017.11.053. Epub 2017 Nov 28.

PMID:
29202439
25.

Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.

Vitrano A, Sacco M, Rosso R, Quota A, Fiorino D, Oliva E, Gerardi C, Roccamo G, Spadola V, Filosa A, Tesé L, Calvaruso G, Pitrolo L, Mistretta L, Cassarà F, Di Maggio R, Maggio A.

Eur J Haematol. 2018 Feb;100(2):124-130. doi: 10.1111/ejh.12989. Epub 2017 Dec 7.

PMID:
29094403
26.

Response to Alpha-Interferon Treatment of the Congenital Dyserythropoietic Anemia type I in Two Sicilian Beta Thalassemia Carriers.

Agrigento V, Barone R, Sclafani S, Di Maggio R, Sacco M, Maggio A, D'Alcamo E.

Indian J Hematol Blood Transfus. 2017 Dec;33(4):621-623. doi: 10.1007/s12288-016-0765-9. Epub 2016 Dec 18.

27.

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.

Megiorni F, Gravina GL, Camero S, Ceccarelli S, Del Fattore A, Desiderio V, Papaccio F, McDowell HP, Shukla R, Pizzuti A, Beirinckx F, Pujuguet P, Saniere L, der Aar EV, Maggio R, De Felice F, Marchese C, Dominici C, Tombolini V, Festuccia C, Marampon F.

J Hematol Oncol. 2017 Oct 6;10(1):161. doi: 10.1186/s13045-017-0530-z.

28.

Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease.

Rossi M, Scarselli M, Fasciani I, Maggio R, Giorgi F.

Acta Neurobiol Exp (Wars). 2017;77(2):113-117. Review.

29.

Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials. Polymorphic substances.

Calvo NL, Maggio RM, Kaufman TS.

J Pharm Biomed Anal. 2018 Jan 5;147:518-537. doi: 10.1016/j.jpba.2017.06.018. Epub 2017 Jun 13. Review.

PMID:
28668295
30.

Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods.

Calvo NL, Maggio RM, Kaufman TS.

J Pharm Biomed Anal. 2018 Jan 5;147:538-564. doi: 10.1016/j.jpba.2017.06.017. Epub 2017 Jun 15. Review.

PMID:
28666554
31.

The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).

Rossi M, Taddei AR, Fasciani I, Maggio R, Giorgi F.

J Endocrinol Invest. 2018 Jan;41(1):67-73. doi: 10.1007/s40618-017-0716-9. Epub 2017 Jun 21. Review.

PMID:
28639207
32.

Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?

Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M.

Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127. Review.

33.

The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.

Di Maggio R, Maggio A.

Br J Haematol. 2017 Sep;178(5):676-688. doi: 10.1111/bjh.14712. Epub 2017 Apr 25. Review.

PMID:
28439891
34.

HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.

Marampon F, Megiorni F, Camero S, Crescioli C, McDowell HP, Sferra R, Vetuschi A, Pompili S, Ventura L, De Felice F, Tombolini V, Dominici C, Maggio R, Festuccia C, Gravina GL.

Cancer Lett. 2017 Jul 1;397:1-11. doi: 10.1016/j.canlet.2017.03.028. Epub 2017 Mar 23.

PMID:
28342984
35.

An integrated analysis of micro- and macro-habitat features as a tool to detect weather-driven constraints: A case study with cavity nesters.

Campobello D, Lindström J, Di Maggio R, Sarà M.

PLoS One. 2017 Mar 20;12(3):e0174090. doi: 10.1371/journal.pone.0174090. eCollection 2017.

36.

The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs.

Rossi M, Fasciani I, Marampon F, Maggio R, Scarselli M.

Mol Pharmacol. 2017 Jun;91(6):586-594. doi: 10.1124/mol.116.107607. Epub 2017 Mar 6. Review.

37.

Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not.

Romeo S, Vitale F, Viaggi C, di Marco S, Aloisi G, Fasciani I, Pardini C, Pietrantoni I, Di Paolo M, Riccitelli S, Maccarone R, Mattei C, Capannolo M, Rossi M, Capozzo A, Corsini GU, Scarnati E, Lozzi L, Vaglini F, Maggio R.

Brain Res. 2017 May 1;1662:87-101. doi: 10.1016/j.brainres.2017.02.026. Epub 2017 Mar 2.

PMID:
28263713
38.

Study on Hydroxyurea Response in Hemoglobinopathies Patients Using Genetic Markers and Liquid Erythroid Cultures.

Sclafani S, Pecoraro A, Agrigento V, Troia A, Di Maggio R, Sacco M, Maggio A, D'Alcamo E, Di Marzo R.

Hematol Rep. 2016 Dec 9;8(4):6678. doi: 10.4081/hr.2016.6678. eCollection 2016 Nov 2.

39.

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?

Vitrano A, Calvaruso G, Lai E, Colletta G, Quota A, Gerardi C, Concetta Rigoli L, Pitrolo L, Cuccia L, Gagliardotto F, Filosa A, Caruso V, Argento C, Campisi S, Rizzo M, Prossomariti L, Fidone C, Fustaneo M, Di Maggio R, Maggio A.

Br J Haematol. 2017 Jan;176(1):124-130. doi: 10.1111/bjh.14381. Epub 2016 Oct 17.

PMID:
27748513
40.

Determination of the main solid-state form of albendazole in bulk drug, employing Raman spectroscopy coupled to multivariate analysis.

Calvo NL, Arias JM, Altabef AB, Maggio RM, Kaufman TS.

J Pharm Biomed Anal. 2016 Sep 10;129:190-197. doi: 10.1016/j.jpba.2016.07.013. Epub 2016 Jul 10.

PMID:
27429368
41.

The mediating role of perceived peer support in the relation between quality of attachment and internalizing problems in adolescence: a longitudinal perspective.

Pace U, Zappulla C, Di Maggio R.

Attach Hum Dev. 2016 Oct;18(5):508-24. doi: 10.1080/14616734.2016.1198919. Epub 2016 Jun 29.

PMID:
27354278
42.

Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation.

Maggio R, Fasciani I, Rossi M, Di Gregorio J, Pietrantoni I, Puca V, Flati V, Scarselli M.

Biochem Soc Trans. 2016 Apr 15;44(2):589-94. doi: 10.1042/BST20150239. Review.

PMID:
27068974
43.

Chemometric applications to assess quality and critical parameters of virgin and extra-virgin olive oil. A review.

Gómez-Caravaca AM, Maggio RM, Cerretani L.

Anal Chim Acta. 2016 Mar 24;913:1-21. doi: 10.1016/j.aca.2016.01.025. Epub 2016 Jan 27. Review.

PMID:
26944986
44.

Preparation and Physical Characterization of a Diclofenac-Ranitidine Co-precipitate for Improving the Dissolution of Diclofenac.

Gaitano RO, Calvo NL, Narda GE, Kaufman TS, Maggio RM, Brusau EV.

J Pharm Sci. 2016 Mar;105(3):1258-68. doi: 10.1016/j.xphs.2016.01.001. Epub 2016 Feb 9.

PMID:
26886308
45.

Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment.

Calvo NL, Kaufman TS, Maggio RM.

J Pharm Biomed Anal. 2016 Apr 15;122:157-65. doi: 10.1016/j.jpba.2016.01.035. Epub 2016 Jan 16.

PMID:
26874854
46.

Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.

Vitrano A, Calvaruso G, Tesé L, Gioia F, Cassarà F, Campisi S, Butera F, Commendatore V, Rizzo M, Santoro V, Cigna V, Quota A, Bagnato S, Argento C, Fidone C, Schembari D, Gerardi C, Barbiera F, Bellisssima G, Giugno G, Polizzi G, Rosso R, Abbate G, Caruso V, Chiodi E, Gamberini MR, Giorgi B, Putti MC, Filosa A, De Ritis MR, Oliva E, Arcadi N, Fustaneo M, Mistretta L, Di Maggio R, Sacco M, Veronica DS, Giangreco A, Maggio A.

Eur J Haematol. 2016 Oct;97(4):361-70. doi: 10.1111/ejh.12740. Epub 2016 Feb 23.

PMID:
26818147
47.

Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.

Schmieg N, Rocchi C, Romeo S, Maggio R, Millan MJ, Mannoury la Cour C.

J Neurochem. 2016 Mar;136(5):1037-51. doi: 10.1111/jnc.13501. Epub 2016 Jan 21.

48.

Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function.

Scarselli M, Annibale P, McCormick PJ, Kolachalam S, Aringhieri S, Radenovic A, Corsini GU, Maggio R.

FEBS J. 2016 Apr;283(7):1197-217. doi: 10.1111/febs.13577. Epub 2015 Nov 28. Review.

49.

Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia.

Vinciguerra M, Passarello C, Cassarà F, Leto F, Cannata M, Calvaruso G, Di Maggio R, Renda D, Maggio A, Giambona A.

Int J Lab Hematol. 2016 Feb;38(1):17-26. doi: 10.1111/ijlh.12433. Epub 2015 Sep 29.

PMID:
26418075
50.

Protective Effect of the Y220C Mutant p53 Against Steatosis: Good News?

Gori M, Barbaro B, Arciello M, Maggio R, Viscomi C, Longo A, Balsano C.

J Cell Physiol. 2015 Jun;230(6):1400. doi: 10.1002/jcp.24874. No abstract available.

PMID:
26179116

Supplemental Content

Loading ...
Support Center